Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 2, 2004, Pages 142-146

  Tse, Chantal ^a   Lefevre, Guillaume ^a   Berkane, Nadia ^a   Flahault, Antoine ^a   Toumi, Karine ^a   Brault, Didier ^a   Capeau, Jacqueline ^a   Uzan, Serge ^a  

^a HÔPITAL TENON   (France)

Author keywords

HER2 ERBB2 p185; Hypertension; p105 protein; Preeclampsia

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ONCOPROTEIN; PROTEIN P105;

ADULT; ANAMNESIS; ARTICLE; CELL TRANSPORT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FEMALE; FETUS; HIGH RISK PREGNANCY; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL SERUM; PARITY; PATHOPHYSIOLOGY; PLACENTA WEIGHT; PLACENTAL TRANSFER; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN DOMAIN; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD PRESSURE; FEMALE; HUMANS; ODDS RATIO; PEPTIDE FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ERBB-2; REFERENCE VALUES; ROC CURVE;

EID: 1642484937     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.026     Document Type: Article

References (18)

1. Alroy I, Yarden Y. The ErbB signalling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 1997;410:83-6.
2. Dougall WC, Qian X, Peterson NC, Miller MJ, Samantha A, Greene MI. The neu oncogene: Signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 1994;9:2109-23.
3. Zabrecki JR, Lam T, McKenzie SJ, Carney W. The extracellular domain of p185/HER2 is released from the surface of human breast carcinoma cells, SK-BR-3. J Biol Chem 1991;226:1716-20.
4. Blobel CP. Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol 2000;12:606-12.
5. Bacus SS, Kiguchi K, Chin D, King CR, Huberman E. Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER2/neu antigen. Mol Carcinog 1990;3:350-62.
6. Quircke P, Pickles A, Tuzi NL, Mohamdee O, Gullick WJ. Pattern of expression of c-erbB-2 oncoprotein in human fetuses. Br J Cancer 1989;60:64-9.
7. Mühlhauser H, Crescimmanno C, Kaufmann P, Höfler H, Zaccheo D, Castellucci M. Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R. J Histochem Cytochem 1993;41:165-73.
8. Murray MJ, Lessey BA. Embryo implantation and tumor metastasis: Common pathways of invasion and angiogenesis. Semin Reprod Endocrinol 1999;17:275-90.
9. Hayes DF, Yamauchi H, Broadwater G, Cirrincione CT, Rodrigue SP, Berry DA, et al. Cancer and leukemia group B. Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662. Clin Cancer Res 2001;7:2703-11.
10. Meden H, Mielke S, Schauer A, Kuhn W. Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment p105 in normal pregnancies. In Vivo 1997;11:51-4.
11. Meden H, Mielke S, Wuttke W, Kuhn W. Elevated serum levels of the c-erbB-2 encoded oncoprotein fragment in cases of pure preeclampsia and HELLP syndrome. J Obstet Gynaecol Res 1997;23:213-7.
12. Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997;177:57-65.
13. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001;184:1249-50.
14. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158-66.
15. Lo YMD, Leung TN, Tein MSC, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-8.
16. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184:414-9.
17. Swinkels DW, De Kok JB, Hendriks CM, Wiegerinck E, Zusterzeel PLM, Steegers EAP. Hemolysis elevated liver enzymes and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002;48:650-3.
18. Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy: Its relevance for preeclampsia. Placenta 1999;20:531-9.